Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.27
+0.71 (5.65%)
At close: Aug 22, 2025, 4:00 PM
13.62
+0.35 (2.64%)
Pre-market: Aug 25, 2025, 7:07 AM EDT
Avantor Market Cap
Avantor has a market cap or net worth of $9.05 billion as of August 25, 2025. Its market cap has decreased by -45.24% in one year.
Market Cap
9.05B
Enterprise Value
12.84B
1-Year Change
-45.24%
Ranking
Category
Stock Price
$13.27
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $9.05B, an increase of 83.59%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 9.05B | -36.92% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |